HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yanzhi Hsu Selected Research

Yanzhi Hsu Research Topics

Disease

9Neoplasms (Cancer)
12/2021 - 09/2002
6Stomach Neoplasms (Stomach Cancer)
01/2019 - 01/2014
5Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2018
5Adenocarcinoma
06/2018 - 01/2014
4Hypertension (High Blood Pressure)
08/2020 - 01/2014
3Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 01/2017
2Neutropenia
12/2021 - 03/2018
2Disease Progression
06/2017 - 01/2014
1Infections
01/2022
1Multiple Sclerosis
01/2022
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2021
1Diarrhea
12/2021
1Lymphoma (Lymphomas)
12/2021
1Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2021
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2021
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2021
1Ascites
08/2020
1Fatigue
08/2020
1Asthenia
08/2020
1Pain (Aches)
01/2020
1Back Pain (Backache)
01/2020
1Weight Loss (Weight Reduction)
01/2020
1Hepatorenal Syndrome
01/2019
1Liver Diseases (Liver Disease)
01/2019
1Liver Neoplasms (Liver Cancer)
01/2019
1Fibrosis (Cirrhosis)
01/2019
1Acute Kidney Injury (Acute Renal Failure)
01/2019
1Renal Insufficiency (Renal Failure)
01/2019
1Febrile Neutropenia
03/2018
1Leukopenia
03/2018
1Neoplasm Metastasis (Metastasis)
06/2017
1Breast Neoplasms (Breast Cancer)
09/2002
1Lung Neoplasms (Lung Cancer)
08/2002

Drug/Important Bio-Agent (IBA)

14RamucirumabIBA
01/2021 - 01/2014
4alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2021 - 01/2018
3Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 10/2017
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2019 - 06/2017
2Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 01/2017
2Irinotecan (Camptosar)FDA LinkGeneric
01/2018 - 01/2017
2PlatinumIBA
06/2017 - 01/2014
2Codon (Codons)IBA
09/2002 - 08/2002
1teriflunomideIBA
01/2022
1ublituximabIBA
01/2022
1umbralisibIBA
12/2021
1Transaminases (Aminotransferases)IBA
12/2021
1Phosphatidylinositols (Phosphatidylinositol)IBA
12/2021
1Biomarkers (Surrogate Marker)IBA
01/2019
1Sorafenib (BAY 43-9006)FDA Link
01/2019
1Fetal Proteins (Fetoprotein)IBA
01/2019
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2017
1Alkaline PhosphataseIBA
06/2017
1AlbuminsIBA
06/2017
1SodiumIBA
06/2017
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2017
1Bevacizumab (Avastin)FDA Link
01/2017
1Carcinoembryonic AntigenIBA
01/2017
1Leucovorin (Folinic Acid)FDA Link
01/2017
1Monoclonal AntibodiesIBA
01/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2014
1Air Pollutants (Pollutants, Air)IBA
10/2002
1DNA AdductsIBA
09/2002
1DNA (Deoxyribonucleic Acid)IBA
09/2002
1DNA Repair EnzymesIBA
09/2002
1polycyclic aromatic hydrocarbons-DNA adductIBA
09/2002
1lysyllysine (Lys-Lys)IBA
08/2002
1tryptophyltryptophanIBA
08/2002

Therapy/Procedure

5Therapeutics
01/2020 - 06/2017
4Drug Therapy (Chemotherapy)
01/2018 - 01/2014